NYSE:CC - Chemours Stock Price, Forecast & News

Chemours' stock was trading at $10.66 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CC shares have decreased by 9.1% and is now trading at $9.69. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 8 hold ratings, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Chemours.

Chemours is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Chemours.

Chemours Co (NYSE:CC) posted its quarterly earnings results on Thursday, February, 13th. The specialty chemicals company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.14. The specialty chemicals company earned $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a negative net margin of 0.92% and a positive return on equity of 52.65%. View Chemours' earnings history.

Chemours announced a quarterly dividend on Wednesday, February 12th. Stockholders of record on Thursday, February 27th will be paid a dividend of $0.25 per share on Monday, March 16th. This represents a $1.00 dividend on an annualized basis and a yield of 10.32%. The ex-dividend date is Wednesday, February 26th. View Chemours' dividend history.

Chemours issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of $2.60-$3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.22.

12 Wall Street analysts have issued twelve-month target prices for Chemours' stock. Their forecasts range from $10.00 to $42.00. On average, they expect Chemours' stock price to reach $19.95 in the next year. This suggests a possible upside of 105.9% from the stock's current price. View analysts' price targets for Chemours.

News articles about CC stock have been trending somewhat negative this week, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Chemours earned a news impact score of -1.9 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutChemours.

Chemours saw a increase in short interest in March. As of March 13th, there was short interest totaling 16,479,800 shares, an increase of 10.5% from the February 27th total of 14,910,000 shares. Based on an average daily trading volume, of 3,190,000 shares, the days-to-cover ratio is currently 5.2 days. Approximately 10.2% of the shares of the stock are sold short. View Chemours' Current Options Chain.

Some companies that are related to Chemours include Johnson Matthey (JMPLY), KURARAY CO LTD/ADR (KURRY), Huntsman (HUN), Balchem (BCPC), Ashland Global (ASH), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Innospec (IOSP), PQ Group (PQG), Ingevity (NGVT), GCP Applied Technologies (GCP), Livent (LTHM), Innophos (IPHS) and Hawkins (HWKN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Energy Transfer LP Unit (ET), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Johnson & Johnson (JNJ).

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CC stock can currently be purchased for approximately $9.69.

Chemours has a market capitalization of $1.59 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. Chemours employs 7,000 workers across the globe. View additional information about Chemours.

The official website for Chemours is http://www.chemours.com/.

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]